Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15857282rdf:typepubmed:Citationlld:pubmed
pubmed-article:15857282lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:15857282lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:15857282lifeskim:mentionsumls-concept:C0014499lld:lifeskim
pubmed-article:15857282lifeskim:mentionsumls-concept:C0067899lld:lifeskim
pubmed-article:15857282pubmed:issue2lld:pubmed
pubmed-article:15857282pubmed:dateCreated2005-4-28lld:pubmed
pubmed-article:15857282pubmed:abstractTextThe aim of this study was to assess the tolerability and efficacy of N-chlorotaurine (NCT), an endogenous antimicrobial agent, in epidemic keratoconjunctivitis. In a prospective double-blind, randomized phase 2b study, the infected eyes were treated for 7 days with eye drops containing 1% aqueous solution of N-chlorotaurine (33 subjects) or gentamicin (27 subjects, control group). Adenovirus types 3, 4, 8, 19, and 37 were detected in 39 subjects (65%), enteroviruses in 8 (13.3%), and staphylococci in 5 (8.3%). Subjective and objective symptoms were scaled and added to a subjective and objective score, respectively, on day 1 (baseline), day 4, and day 8. Analyzing the whole study population, the subjective score on day 8 was lower in the NCT group (P = 0.016), whereas there were no differences in the objective score. However, in severe infections caused by adenovirus type 8 (n = 20) both the subjective and objective score were lower in the NCT group on day 4 (P = 0.003 and 0.015, respectively), which was also true for the subjective score on day 8 (P = 0.004) in this subgroup. The frequency of subepithelial infiltrates was similar in both groups. N-chlorotaurine was well-tolerated, shortened the duration of illness, and seems to be a useful causative therapeutic approach in severe epidemic keratoconjunctivitis.lld:pubmed
pubmed-article:15857282pubmed:languageenglld:pubmed
pubmed-article:15857282pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15857282pubmed:citationSubsetIMlld:pubmed
pubmed-article:15857282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15857282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15857282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15857282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15857282pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15857282pubmed:statusMEDLINElld:pubmed
pubmed-article:15857282pubmed:monthAprlld:pubmed
pubmed-article:15857282pubmed:issn1080-7683lld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:IshikoHiroaki...lld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:OhnoShigeakiSlld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:UlmerHannoHlld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:NaglMarkusMlld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:LarcherClaraClld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:TeuchnerBarba...lld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:AokiKokiKlld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:GottardiWalde...lld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:MizukiNobuhis...lld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:DragositsErns...lld:pubmed
pubmed-article:15857282pubmed:authorpubmed-author:SchidlbauerAx...lld:pubmed
pubmed-article:15857282pubmed:issnTypePrintlld:pubmed
pubmed-article:15857282pubmed:volume21lld:pubmed
pubmed-article:15857282pubmed:ownerNLMlld:pubmed
pubmed-article:15857282pubmed:authorsCompleteYlld:pubmed
pubmed-article:15857282pubmed:pagination157-65lld:pubmed
pubmed-article:15857282pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:meshHeadingpubmed-meshheading:15857282...lld:pubmed
pubmed-article:15857282pubmed:year2005lld:pubmed
pubmed-article:15857282pubmed:articleTitleTolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis--a double-blind, randomized, phase-2 clinical trial.lld:pubmed
pubmed-article:15857282pubmed:affiliationDepartment of Ophthalmology, Innsbruck Medical University, Innsbruck, Austria.lld:pubmed
pubmed-article:15857282pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15857282pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15857282pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:15857282pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15857282pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15857282lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15857282lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15857282lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15857282lld:pubmed